194 related articles for article (PubMed ID: 23238665)
1. Health care costs in people with diabetes and their association with glycemic control and kidney function.
McBrien KA; Manns BJ; Chui B; Klarenbach SW; Rabi D; Ravani P; Hemmelgarn B; Wiebe N; Au F; Clement F
Diabetes Care; 2013 May; 36(5):1172-80. PubMed ID: 23238665
[TBL] [Abstract][Full Text] [Related]
2. Glycemic control according to glomerular filtration rate in patients with type 2 diabetes and overt nephropathy: a prospective observational study.
Joly D; Choukroun G; Combe C; Dussol B; Fauvel JP; Halimi JM; Quéré S; Fiquet B
Diabetes Res Clin Pract; 2015 Apr; 108(1):120-7. PubMed ID: 25726333
[TBL] [Abstract][Full Text] [Related]
3. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
[TBL] [Abstract][Full Text] [Related]
4. Effect of improved glycemic control on health care costs and utilization.
Wagner EH; Sandhu N; Newton KM; McCulloch DK; Ramsey SD; Grothaus LC
JAMA; 2001 Jan; 285(2):182-9. PubMed ID: 11176811
[TBL] [Abstract][Full Text] [Related]
5. The cost to health plans of poor glycemic control.
Gilmer TP; O'Connor PJ; Manning WG; Rush WA
Diabetes Care; 1997 Dec; 20(12):1847-53. PubMed ID: 9405905
[TBL] [Abstract][Full Text] [Related]
6. Health and economic effects of adding nateglinide to metformin to achieve dual control of glycosylated hemoglobin and postprandial glucose levels in a model of type 2 diabetes mellitus.
Salas M; Ward A; Caro J
Clin Ther; 2002 Oct; 24(10):1690-705. PubMed ID: 12462297
[TBL] [Abstract][Full Text] [Related]
7. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.
Hayward RA; Manning WG; Kaplan SH; Wagner EH; Greenfield S
JAMA; 1997 Nov; 278(20):1663-9. PubMed ID: 9388085
[TBL] [Abstract][Full Text] [Related]
8. Potential short-term economic benefits of improved glycemic control: a managed care perspective.
Menzin J; Langley-Hawthorne C; Friedman M; Boulanger L; Cavanaugh R
Diabetes Care; 2001 Jan; 24(1):51-5. PubMed ID: 11194241
[TBL] [Abstract][Full Text] [Related]
9. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.
Shurraw S; Hemmelgarn B; Lin M; Majumdar SR; Klarenbach S; Manns B; Bello A; James M; Turin TC; Tonelli M;
Arch Intern Med; 2011 Nov; 171(21):1920-7. PubMed ID: 22123800
[TBL] [Abstract][Full Text] [Related]
10. Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
JAMA Netw Open; 2020 Jan; 3(1):e1919099. PubMed ID: 31922562
[TBL] [Abstract][Full Text] [Related]
11. Impact of a Telephonic Intervention to Improve Diabetes Control on Health Care Utilization and Cost for Adults in South Bronx, New York.
Tabaei BP; Howland RE; Gonzalez JS; Chamany S; Walker EA; Schechter CB; Wu WY
Diabetes Care; 2020 Apr; 43(4):743-750. PubMed ID: 32132009
[TBL] [Abstract][Full Text] [Related]
12. Population based screening for chronic kidney disease: cost effectiveness study.
Manns B; Hemmelgarn B; Tonelli M; Au F; Chiasson TC; Dong J; Klarenbach S;
BMJ; 2010 Nov; 341():c5869. PubMed ID: 21059726
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study.
Achila OO; Ghebretinsae M; Kidane A; Simon M; Makonen S; Rezene Y
J Diabetes Res; 2020; 2020():5901569. PubMed ID: 32090121
[TBL] [Abstract][Full Text] [Related]
14. Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.
Busch M; Nadal J; Schmid M; Paul K; Titze S; Hübner S; Köttgen A; Schultheiss UT; Baid-Agrawal S; Lorenzen J; Schlieper G; Sommerer C; Krane V; Hilge R; Kielstein JT; Kronenberg F; Wanner C; Eckardt KU; Wolf G;
BMC Nephrol; 2016 Jun; 17(1):59. PubMed ID: 27286816
[TBL] [Abstract][Full Text] [Related]
15. The Cost of Care for People With Chronic Kidney Disease.
Manns B; Hemmelgarn B; Tonelli M; Au F; So H; Weaver R; Quinn AE; Klarenbach S;
Can J Kidney Health Dis; 2019; 6():2054358119835521. PubMed ID: 31057803
[TBL] [Abstract][Full Text] [Related]
16. Association Between Routine Nephropathy Monitoring and Subsequent Change in Estimated Glomerular Filtration Rate in Patients With Diabetes Mellitus: A Japanese Non-Elderly Cohort Study.
Ono S; Ono Y; Koide D; Yasunaga H
J Epidemiol; 2020 Aug; 30(8):326-331. PubMed ID: 31204363
[TBL] [Abstract][Full Text] [Related]
17. Point-of-Care Hemoglobin A1c Testing: A Budget Impact Analysis.
Chadee A; Blackhouse G; Goeree R
Ont Health Technol Assess Ser; 2014; 14(9):1-23. PubMed ID: 26316923
[TBL] [Abstract][Full Text] [Related]
18. Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population.
Meng J; Casciano R; Lee YC; Stern L; Gultyaev D; Tong L; Kitio-Dschassi B
J Manag Care Spec Pharm; 2017 Apr; 23(4):446-452. PubMed ID: 28345434
[TBL] [Abstract][Full Text] [Related]
19. Annual deterioration of renal function in hypertensive patients with and without diabetes.
Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
[TBL] [Abstract][Full Text] [Related]
20. OPEN ACCESS TO DIABETES CENTER FROM THE EMERGENCY DEPARTMENT REDUCES HOSPITALIZATIONS IN THE SUSEQUENT YEAR.
Palermo NE; Modzelewski KL; Farwell AP; Fosbroke J; Shankar KN; Alexanian SM; Baker WE; Simonson DC; McDonnell ME
Endocr Pract; 2016 Oct; 22(10):1161-1169. PubMed ID: 27732094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
